The relationship of soluble TREM2 to other biomarkers of sporadic Alzheimer’s disease
Abstract Microglial activation is a central player in the pathophysiology of Alzheimer’s disease (AD). The soluble fragment of triggering receptor expressed on myeloid cells 2 (sTREM2) can serve as a marker for microglial activation and has been shown to be overexpressed in AD. However, the relation...
Main Authors: | So-Hee Park, Eun-Hye Lee, Hyung-Ji Kim, Sungyang Jo, Sunju Lee, Sang Won Seo, Hyun-Hee Park, Seong-Ho Koh, Jae-Hong Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-06-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-92101-6 |
Similar Items
-
TREM2 ectodomain and its soluble form in Alzheimer’s disease
by: Jiaolong Yang, et al.
Published: (2020-07-01) -
The Emerging Roles and Therapeutic Potential of Soluble TREM2 in Alzheimer’s Disease
by: Li Zhong, et al.
Published: (2019-11-01) -
Genome-Wide Association Studies for Cerebrospinal Fluid Soluble TREM2 in Alzheimer’s Disease
by: Changan Liu, et al.
Published: (2019-10-01) -
False Memory and Alzheimer’s Disease Pathology in Patients with Amnestic Mild Cognitive Impairment: A Study with Amyloid PET
by: Eun-Ji Choi, et al.
Published: (2021-06-01) -
Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers
by: Nicholas J. Ashton, et al.
Published: (2019-11-01)